A retrospective cohort study of the new documentary “You Can See Everything” has identified a statistically significant correlation between former Theranos CEO Elizabeth Holmes moving her lips and the active transmission of falsehoods. However, experts caution that more research is needed to establish a definitive link.
The preliminary findings, compiled by lead investigator and former Theranos whistleblower Tyler Shultz, examined hours of self-reported camera footage. Shultz noted that while the documentary provides a robust sample size of Holmes’s current claims, the data is inherently limited by an observational methodology that only tracks the specific narratives the subject chose to record.
According to the protocol published by Shultz, audiences are observing a highly elevated incidence of fabrication within this specific media environment, but medical observers warn against drawing hasty conclusions. Analysts emphasized that Holmes’s previous federal conviction on four counts of wire fraud should be treated only as an underlying risk factor, rather than a diagnostic certainty for her current behavior.
While the data strongly suggests a chronic, systemic pathology of lying, we cannot definitively rule out that she is simply experiencing a localized flare-up of aggressive marketing.
Furthermore, peer reviewers have raised methodological concerns about the documentary’s title, “You Can See Everything.” Independent clinical boards suggest the branding is highly misleading, arguing a more medically accurate label would explicitly disclose that viewers are only being exposed to the specific symptoms the pathogen has chosen to exhibit under controlled lighting.
The FDA has thus far declined to issue a black-box warning for the streaming release, citing a lack of randomized, double-blind trials comparing Holmes’s on-camera statements to objective reality. Shultz has advised audiences to maintain a prophylactic barrier of extreme skepticism when exposed to the footage, though he stressed this regimen remains entirely off-label.